Alex Denner is out at Biogen as new CEO Viehbacher crafts a fresh board with Susan Langer, Caroline Dorsa

John Carroll

Editor & Founder

Biogen’s big top-level shakeup continued Monday evening with news that Alex Denner — first elected to the board back in 2009 when he spearheaded Carl Icahn …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Alex Denner is out at Biogen as new CEO Viehbacher crafts a fresh board with Susan Langer, Caroline Dorsa

John Carroll

Editor & Founder

Sign up to read this article for free.

Director Oligonucleotide R&D

Bachem

Bubendorf, BL, Switzerland

Trump’s science crackdown hits rare disease research: ‘We need to sit down with Elon Musk’

BridgeBio oncology spinout to go public via combination with SPAC from Cormorant and Bihua Chen

Lilly joins molecular glue field with Magnet deal worth up to $1.25B

Pfizer vet William Pao’s next venture; Sanofi’s computational science exec leaves

Exclusive: Infectious disease doctors consider 'mini-ACIP' if RFK erodes CDC vaccine panel

How AI can address ongoing challenges in the life sciences industry

Alex Den­ner is out at Bio­gen as new CEO Viehbach­er crafts a fresh board with Su­san Langer, Car­o­line Dor­sa

Editor & Founder

Sign up to read this article for free.

Bachem

Bubendorf, BL, Switzerland

Alex Denner is out at Biogen as new CEO Viehbacher crafts a fresh board with Susan Langer, Caroline Dorsa